Cart
sales@molnova.com
PKG inhibitor peptide TFA
CAS No.
PKG inhibitor peptide TFA ( )
Catalog No. M30222 CAS No.
PKG inhibitor peptide TFA is an inhibitor of atp-competitive cGMP-dependent protein kinase (PKG), Ki 86 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NamePKG inhibitor peptide TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionPKG inhibitor peptide TFA is an inhibitor of atp-competitive cGMP-dependent protein kinase (PKG), Ki 86 μM.
-
DescriptionPKG inhibitor peptide TFA is an inhibitor of atp-competitive cGMP-dependent protein kinase (PKG), Ki 86 μM.(In Vitro):PKG inhibitor peptide TFA binds to cGMP-dependent protein kinase directly with a Ki of 86 μM.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
RecptorKi: 86 μM (PKG)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number--
-
Formula Weight1057.1
-
Molecular FormulaC40H75F3N18O12
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Bhatnagar D, et al. Synthetic peptide analogues differentially alter the binding affinities of cyclic nucleotide dependent protein kinases for nucleotide substrates. Biochemistry. 1988 Mar 22;27(6):1988-94.
molnova catalog
related products
-
Ganoderic acid N
23-Dihydroganoderic Acid N has anticancer effects.
-
6-Aminocaproic acid
6-Aminocaproic acid is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
-
Ivermectin B1a
Ivermectin B1a is the major (80%) component of commercially available ivermectin and a derivative of Avermectin B1a.
